Entries by admin

4P-Pharma appoints Patrice Denèfle as Chief Scientific Officer

4P-Pharma, a biotechnology company specialised in the sourcing and the development of early stage therapeutic molecules, announces the appointment of Patrice Denèfle, PhD, HDR, Adjunct Prof., as its Chief Scientific Officer (CSO).  “We are delighted to welcome Patrice to our team as Chief Scientific Officer. […] I look forward to work closely with him to […]

4P-Pharma at BIO Europe Spring 2020

Roselina Lam, our Business Development and Licensing Manager, will attend the upcoming BIO Europe Spring on March 23rd-25th, 2020 in Paris, France. Contact her via the partnering platform or by e-mail, to learn more about our pipeline and discuss future partnerships. She is looking forward to meet you there!

4P-Pharma received the Seal of Excellence from the European Commission

4P-Pharma received the Seal of Excellence from the European Commission for its application related to the development of a disease modifier treatment for osteoarthritis, 4P-004 to the Horizon 2020 EIC Accelerator (SME instrument). Following evaluation by an international panel of independent experts, 4P-Pharma’s project was scored as a high-quality proposal in this highly competitive evaluation […]

4P-Pharma au Deeptech tour de Bpifrance à Paris-Sorbonne Université

Revital Rattenbach, CEO de 4P-Pharma, sera l’ambassadrice du Deeptech tour organisé par Bpifrance au Centre International de Conférences de Sorbonne Université à Paris le 9 mars 2020. Elle interviendra lors de la session plénière en tant qu’entrepreneur de l’écosystème. Lien de l’évènement et programme : http://deeptechtoursorbonne.evenium-site.com/site/le-deeptech-tour-sorbonne-universite;jsessionid=UE6Dr4FnVKg!bwsMI8rdesYe.gl2

4P-Pharma at Biotech Showcase 2020

4P-Pharma’s CEO, Revital Rattenbach, will attend the upcoming Biotech Showcase 2020 in San Francisco (USA), January 13th-15th, 2020. Contact us via the partnering platform or by e-mail to schedule a meeting and discuss future collaborations.